Atricure Inc (ATRC) concluded trading on Thursday at a closing price of $32.01, with 0.45 million shares of worth about $14.41 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.88% during that period and on April 17, 2025 the price saw a loss of about -0.22%. Currently the company’s common shares owned by public are about 48.87M shares, out of which, 47.72M shares are available for trading.
Stock saw a price change of 1.17% in past 5 days and over the past one month there was a price change of -8.07%. Year-to-date (YTD), ATRC shares are showing a performance of 4.74% which increased to 38.57% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $18.94 but also hit the highest price of $43.11 during that period. The average intraday trading volume for Atricure Inc shares is 574.88K. The stock is currently trading -2.31% below its 20-day simple moving average (SMA20), while that difference is down -10.27% for SMA50 and it goes to 2.26% higher than SMA200.
Atricure Inc (NASDAQ: ATRC) currently have 48.87M outstanding shares and institutions hold larger chunk of about 94.93% of that.
The stock has a current market capitalization of $1.58B and its 3Y-monthly beta is at 1.51. It has posted earnings per share of -$0.95 in the same period. It has Quick Ratio of 2.62 while making debt-to-equity ratio of 0.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATRC, volatility over the week remained 4.63% while standing at 6.57% over the month.
Analysts are in expectations that Atricure Inc (ATRC) stock would likely to be making an EPS of -0.22 in the current quarter, while forecast for next quarter EPS is -0.15 and it is -0.4 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.27 which is -0.15 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.25 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 27.64% while it is estimated to increase by 38.43% in next year. EPS is likely to grow at an annualized rate of 64.76% for next 5-years, compared to annual growth of -0.33% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on December 17, 2024 offering an Overweight rating for the stock and assigned a target price of $40 to it. Coverage by Oppenheimer stated Atricure Inc (ATRC) stock as an Outperform in their note to investors on April 23, 2024, suggesting a price target of $32 for the stock. On October 23, 2023, JMP Securities Initiated their recommendations, while on September 29, 2023, UBS Initiated their ratings for the stock with a price target of $56. Stock get a Perform rating from Oppenheimer on August 05, 2021.
